Post by Paul Ko

At our core, we are a company obsessed with the frontiers of genetic engineering. We work on the long-term code of life. However, in the process of researching cellular signaling and tissue regeneration, we stumbled upon a "Black Swan" - a discovery so disruptive to Emergency Medicine that we realized we couldn't just leave it on the shelf. We’ve developed Soft-gel-CHIMERA: A robotic, plasma-based limb-salvage system that bridges the gap between fatal trauma and the operating table. But we are realists. We know the medical industry is a fortress of lobbying, graft, and institutional inertia. #MedTech #EmergencyMedicine #Disruption #VentureCapital #BioEngineering #Innovation #TraumaCare #ChimeraProject #DefenseTech #SurgicalRobotics #Epigenetics